Vaxart (VXRT) Tops Q2 EPS by 6c

Vaxart (NASDAQ: VXRT) reported Q2 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $66.67 thousand.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Chevron, Microsoft strike 20-year deal to power massive AI data center
• Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer